Grundinformationen
- Standard-SMILES
CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](C)(O)CC(=O)O- InChIKey
CABVTRNMFUVUDM-VRHQGPGLSA-N- Summenformel
- C27H44N7O20P3S
- Durchschnittliche Molmasse
- 911,7 g/mol
- Monoisotopische Masse
- 911,15746899
Namen und Bezeichner
- Bevorzugter Name
- HMG-CoA
- IUPAC
- (3S)-5-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-3-hydroxy-3-methyl-5-oxopentanoic acid
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
1553-55-5、26926-09-0- PubChem CID
- 445127
- DTXSID
DTXSID40862689- ChEMBL
CHEMBL1794644- ChEBI
CHEBI:15467- EC Number
- 216-301-7
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- -6,6
- Polarare Oberfläche (TPSA)
- 446 Ų
- H-Brücken-Donoren
- 11
- H-Brücken-Akzeptoren
- 25
- Frei drehbare Bindungen
- 24
- Schwere Atome
- 58
- Formalladung
- 0
- Komplexität
- 1.610
Experimentelle und physikochemische Eigenschaften
Collision Cross Section
265.4 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)];261.9 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)];266.2 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)];267.3 Ų [M+Na-2H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]
259.35 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
Chemie und Industrie
Pharmakologische Informationen
Metabolite Pathways
2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;3-hydroxyisobutyric acid dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;3-Methylglutaconic Aciduria Type I;3-Methylglutaconic Aciduria Type III;3-Methylglutaconic Aciduria Type IV;Alendronate Action Pathway;Atorvastatin Action Pathway;Total 43 pathways, visit the HMDB page for details
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…